Borgeson Blake
Insider CIK 1856094 · RXRX Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2026-10-06 | 2026-10-07 | 50,000 | $4.84 | $242.0K | 6,108,287 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2026-09-01 | 2026-09-02 | 30,000 | $3.34 | $100.2K | 6,158,287 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2026-09-01 | 2026-09-02 | 30,000 | $3.34 | $100.2K | 6,158,287 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2026-08-04 | 2026-08-06 | 30,000 | $3.25 | $97.5K | 6,188,287 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2026-08-04 | 2026-08-06 | 30,000 | $3.25 | $97.5K | 6,188,287 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2026-07-07 | 2026-07-09 | 40,000 | $3.96 | $158.4K | 6,218,287 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2026-06-17 | 2026-06-22 | 88,424 | — | $0 | 6,258,287 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2026-06-02 | 2026-06-04 | 30,000 | $3.68 | $110.4K | 6,169,863 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2026-05-05 | 2026-05-07 | 30,000 | $3.52 | $105.6K | 6,199,863 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2026-04-07 | 2026-04-08 | 30,000 | $3.10 | $93.0K | 6,229,863 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2026-03-03 | 2026-03-04 | 170,000 | $3.46 | $588.2K | 6,259,863 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2026-02-03 | 2026-02-06 | 220,000 | $4.20 | $924.0K | 6,429,863 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2026-01-06 | 2026-01-08 | 220,000 | $4.36 | $959.2K | 6,649,863 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2025-12-02 | 2025-12-04 | 220,000 | $4.37 | $961.4K | 6,869,863 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award deriv | 2025-06-18 | 2025-06-23 | 44,031 | — | $0 | 44,031 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2025-06-18 | 2025-06-23 | 22,016 | — | $0 | 7,089,863 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2025-01-02 | 2025-01-06 | 1,734 | — | $0 | 7,067,847 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2024-11-12 | 2024-11-14 | 11,447 | $7.64 | $87.5K | 7,066,113 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2024-10-29 | 2024-10-31 | 11,447 | $6.72 | $76.9K | 7,077,560 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2024-10-15 | 2024-10-17 | 11,447 | $6.67 | $76.4K | 7,089,007 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2024-10-01 | 2024-10-03 | 11,447 | $6.22 | $71.2K | 7,098,428 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2024-10-01 | 2024-10-04 | 2,026 | — | $0 | 7,100,454 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2024-09-17 | 2024-09-19 | 11,447 | $6.84 | $78.3K | 7,109,875 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2024-09-03 | 2024-09-05 | 11,447 | $6.27 | $71.8K | 7,121,322 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2024-08-20 | 2024-08-22 | 11,447 | $7.12 | $81.5K | 7,132,769 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2024-08-06 | 2024-08-08 | 11,447 | $6.82 | $78.1K | 7,144,216 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2024-07-23 | 2024-07-25 | 11,447 | $8.48 | $97.1K | 7,155,663 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2024-07-09 | 2024-07-11 | 11,447 | $7.32 | $83.8K | 7,167,110 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2024-07-01 | 2024-07-03 | 1,441 | — | $0 | 7,178,557 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2024-06-25 | 2024-06-27 | 11,447 | $9.51 | $108.9K | 7,177,116 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2024-06-11 | 2024-06-13 | 11,447 | $8.45 | $96.7K | 7,188,563 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award deriv | 2024-06-03 | 2024-06-05 | 26,193 | — | $0 | 26,193 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2024-06-03 | 2024-06-05 | 13,097 | — | $0 | 7,200,010 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2024-05-28 | 2024-05-30 | 11,447 | $9.17 | $105.0K | 7,186,913 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2024-05-14 | 2024-05-16 | 20,054 | $10.12 | $202.9K | 7,198,360 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2024-04-30 | 2024-05-02 | 11,447 | $7.95 | $91.0K | 7,218,414 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2024-04-16 | 2024-04-18 | 11,447 | $7.66 | $87.7K | 7,229,861 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2024-04-02 | 2024-04-03 | 11,447 | $8.82 | $101.0K | 7,241,308 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2024-03-19 | 2024-03-21 | 20,054 | $10.79 | $216.4K | 7,252,755 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2024-03-05 | 2024-03-07 | 20,054 | $12.06 | $241.9K | 7,272,809 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2024-02-20 | 2024-02-21 | 19,745 | $12.31 | $243.1K | 7,293,172 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2024-02-20 | 2024-02-21 | 309 | $13.04 | $4.0K | 7,292,863 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2024-02-06 | 2024-02-08 | 11,447 | $9.30 | $106.5K | 7,312,917 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2024-01-23 | 2024-01-25 | 20,054 | $10.58 | $212.2K | 7,324,364 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2024-01-09 | 2024-01-11 | 6,303 | $13.21 | $83.3K | 7,358,169 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2024-01-09 | 2024-01-11 | 13,751 | $13.81 | $189.9K | 7,344,418 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2023-12-26 | 2023-12-28 | 20,054 | $10.63 | $213.2K | 7,364,472 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2023-12-12 | 2023-12-14 | 11,447 | $7.40 | $84.7K | 7,384,526 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2023-11-28 | 2023-11-30 | 11,447 | $6.72 | $76.9K | 7,395,973 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2023-11-14 | 2023-11-16 | 8,885 | $6.32 | $56.2K | 7,407,420 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2023-10-31 | 2023-11-02 | 8,885 | $5.27 | $46.8K | 7,416,305 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2023-10-17 | 2023-10-19 | 8,885 | $6.58 | $58.5K | 7,425,190 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2023-10-03 | 2023-10-05 | 8,885 | $7.29 | $64.8K | 7,434,075 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2023-09-19 | 2023-09-21 | 8,885 | $8.36 | $74.3K | 7,442,960 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2023-09-05 | 2023-09-07 | 8,885 | $8.79 | $78.1K | 7,451,845 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2023-08-22 | 2023-08-24 | 8,885 | $8.91 | $79.2K | 7,460,730 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2023-08-08 | 2023-08-10 | 3,272 | $11.75 | $38.4K | 7,469,615 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2023-08-08 | 2023-08-10 | 14,498 | $11.03 | $159.9K | 7,472,887 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2023-07-25 | 2023-07-27 | 18,719 | $14.61 | $273.5K | 7,487,385 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2023-07-11 | 2023-07-13 | 8,885 | $6.89 | $61.2K | 7,520,104 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | G Gift | 2023-06-29 | 2023-07-27 | 14,000 | — | $0 | 7,506,104 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2023-06-27 | 2023-06-29 | 8,885 | $7.39 | $65.7K | 7,528,989 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award deriv | 2023-06-16 | 2023-06-21 | 25,224 | — | $0 | 25,224 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2023-06-16 | 2023-06-21 | 12,612 | — | $0 | 7,537,874 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2023-06-13 | 2023-06-15 | 15,485 | $9.98 | $154.5K | 7,525,262 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2023-05-30 | 2023-06-01 | 8,885 | $8.79 | $78.1K | 7,540,747 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2023-05-16 | 2023-05-17 | 8,885 | $5.09 | $45.2K | 7,549,632 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2023-04-18 | 2023-04-20 | 8,885 | $5.93 | $52.7K | 7,558,517 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2023-04-04 | 2023-04-06 | 8,885 | $6.53 | $58.0K | 7,567,402 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2023-03-21 | 2023-03-23 | 8,885 | $7.40 | $65.7K | 7,576,287 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2023-03-07 | 2023-03-09 | 8,885 | $8.33 | $74.0K | 7,585,172 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2023-02-21 | 2023-02-23 | 8,885 | $7.73 | $68.7K | 7,594,057 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2023-02-07 | 2023-02-09 | 8,885 | $8.81 | $78.3K | 7,602,942 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2023-01-24 | 2023-01-26 | 8,885 | $8.71 | $77.4K | 7,611,827 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2023-01-10 | 2023-01-12 | 8,885 | $7.69 | $68.3K | 7,620,712 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2023-01-03 | 2023-01-05 | 1,325 | — | $0 | 7,629,597 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2022-12-27 | 2022-12-29 | 8,885 | $7.25 | $64.4K | 7,628,272 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2022-12-13 | 2022-12-15 | 8,885 | $8.96 | $79.6K | 7,637,157 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2022-11-29 | 2022-12-01 | 8,885 | $8.75 | $77.7K | 7,646,042 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2022-11-16 | 2022-11-18 | 17,770 | $11.12 | $197.6K | 7,654,927 | SEC↗ |
| RXRX | A Award | 2022-10-03 | 2022-10-05 | 920 | — | $0 | 7,672,697 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2022-07-01 | 2022-07-06 | 1,186 | — | $0 | 7,671,777 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award deriv | 2022-06-14 | 2022-06-16 | 36,290 | — | $0 | 36,290 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2022-06-14 | 2022-06-16 | 18,145 | — | $0 | 7,670,591 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2022-04-01 | 2022-04-05 | 1,300 | — | $0 | 7,652,446 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2022-01-04 | 2022-01-05 | 9,625 | $18.03 | $173.5K | 7,651,146 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2022-01-03 | 2022-01-05 | 555 | — | $0 | 7,660,771 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2021-12-21 | 2021-12-23 | 9,625 | $18.75 | $180.5K | 7,660,216 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2021-12-07 | 2021-12-09 | 1,500 | $19.78 | $29.7K | 7,677,966 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2021-12-07 | 2021-12-09 | 7,725 | $20.38 | $157.4K | 7,670,241 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2021-12-07 | 2021-12-09 | 400 | $21.03 | $8.4K | 7,669,841 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2021-11-18 | 2021-11-22 | 7,725 | $19.05 | $147.2K | 7,679,466 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2021-11-18 | 2021-11-22 | 1,900 | $18.32 | $34.8K | 7,687,191 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2021-10-01 | 2021-10-05 | 457 | — | $0 | 7,689,091 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2021-07-01 | 2021-07-06 | 278 | — | $0 | 7,688,634 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | C Conversion deriv | 2021-04-20 | 2021-04-22 | 12,500 | — | $0 | 0 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | C Conversion deriv | 2021-04-20 | 2021-04-22 | 378,309 | — | $0 | 0 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | C Conversion deriv | 2021-04-20 | 2021-04-22 | 12,500 | — | $0 | 12,500 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | C Conversion deriv | 2021-04-20 | 2021-04-22 | 544,743 | — | $0 | 0 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | C Conversion | 2021-04-20 | 2021-04-22 | 7,688,356 | — | $0 | 0 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | C Conversion | 2021-04-20 | 2021-04-22 | 923,052 | — | $0 | 7,688,356 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | C Conversion | 2021-04-20 | 2021-04-22 | 7,688,356 | — | $0 | 7,688,356 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2021-04-16 | 2021-04-19 | 6,250 | — | $0 | 6,765,304 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award deriv | 2021-04-15 | 2021-04-19 | 12,500 | — | $0 | 12,500 | SEC↗ |